Detection of cutaneous oxygen saturation using a novel snapshot hyperspectral camera: a feasibility study von Manen, L. van, Birkhoff, W.A.J., Eggermont, J., Hoveling, R.J.M., Nicklin, P., Burggraaf, J., Wilson, R., Mieog, J.S.D., Robinson, D.J., Vahrmeijer, A.L., Bradbury, M.S., Dijkstra, J.

Volltext bestellen

Reducing uncertainties in structure gauging von Bradbury, W M S, Westwood, T

Volltext

The importance of convective gusts von Bradbury, W M S, Deaves, D M, Hunt, J C R, Kershaw, R, Nakamura, K, Hardman, M E, Bearman, P W

Volltext

Graduated Compression Stockings as an Adjunct to Low Dose Low Molecular Weight Heparin in Venous Thromboembolism Prevention in Surgery: A Multicentre Randomised Controlled Trial von Shalhoub, J, Norrie, J, Baker, C, Bradbury, A.W, Dhillon, K, Everington, T, Gohel, M.S, Hamady, Z, Heatley, F, Hudson, J, Hunt, B.J, Lawton, R, Stansby, G, Stephens-Boal, A, Toh, S, Warwick, D, Davies, A.H

Volltext

EP.12A.09 Oligoprogression and Osimertinib Continuation Post-progression in Patients with EGFR-Mutations von Mai, V., Lee, J., Zhan, L., Brown, M.C., Balaratnam, K., Khan, K., Cheng, S., Barghout, S., Al-Agha, F., Raptis, R., Kuang, K., Eng, L., Sacher, A.G., Bradbury, P.A., Leighl, N.B., Cabanero, M., Hsu, R., Pal, P., Tsao, M.S., Shepherd, F.A., Xu, W., Liu, G.

Volltext

1298P PD-1 inhibitors combined with chemotherapy may preferentially improve survival in metastatic NSCLC with myeloid-mediated primary resistance to immunotherapy von Lau, S.C., Elliott, M.J., Rabinovitch, A., Makarem, M., Kuang, S., Schmid, S., Sharma, K., Lee, J., Mackay, K.M., Wong, S.W., Wang, B.X., Ohashi, P.S., Tsao, M.S., Shepherd, F.A., Bradbury, P., Liu, G., Leighl, N., McGaha, T., Sacher, A.

Volltext

1809P Evaluation of KRAS mutation subtype on survival in patients with metastatic non-small cell lung cancer receiving immunotherapy von Barron, C.C., Kuang, S., Makarem, M., Elliott, M.J., Sharma, K., Lee, J., Schmid, S., Rabinovitch, A., Bradbury, P., Liu, G., Shepherd, F.A., Tsao, M.S., Leighl, N., Rose, A., Pezo, R., Doherty, M., Cheng, S., Lau, S.C., Sacher, A.

Volltext

607 NCIC CTG IND.196: Phase I Study of Foretinib (GSK1363089) and Erlotinib in Patients with Advanced Pretreated NSCLC von Leighl, N.B, Tsao, M.S, Ho, C, Shepherd, F.A, Murray, N, Goffin, J, Nicholas, G, Seymour, L, Goss, G.D, Bradbury, P

Volltext